Past its pain-relieving outcomes, conolidine has demonstrated a good basic safety margin in preclinical toxicology assessments. Compared with opioids, which frequently result in respiratory depression at bigger doses, conolidine has not created indications of major respiratory suppression. In addition, behavioral assessments in murine designs propose an absence of drug-in https://carsonr837twr9.wikibriefing.com/user